Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Karuna Therapeutics Inc (KRTX)

Karuna Therapeutics Inc (KRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Karuna Therapeutics Inc 99 HIGH STREET 26TH FLOOR BOSTON MA 02110 USA

karunatx.com P: 857-449-2244

Description:

Karuna Therapeutics Inc. is a clinical-stage biopharmaceutical company. It is primarily focused on developing novel therapies to address disabling neuropsychiatric conditions characterized by significant unmet medical needs. The company's product candidate consists of KarXT, for the treatment of acute psychosis in patients with schizophrenia, which are in clinical stage. Karuna Therapeutics Inc. is based in Boston, Massachusetts.

Key Statistics

Overview:

Market Capitalization, $K 12,582,351
Enterprise Value, $K 12,396,531
Shares Outstanding, K 38,148
Annual Sales, $ 650 K
Annual Net Income, $ -433,680 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -113,820 K
EBIT, $ -494,790 K
EBITDA, $ -531,060 K
60-Month Beta 1.18
% of Insider Shareholders 13.20%
Float, K 33,112
% Float 86.80%
Short Volume Ratio 0.35

Growth:

1-Year Return 76.31%
3-Year Return 182.65%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -3.01 on 02/22/24
Latest Earnings Date 05/02/24
Earnings Per Share ttm -11.72
EPS Growth vs. Prev Qtr 4.75%
EPS Growth vs. Prev Year -35.59%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

KRTX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -31.63%
Return-on-Assets % -30.38%
Profit Margin % -66,720.00%
Debt/Equity 0.00
Price/Sales 19,233.82
Price/Cash Flow N/A
Price/Book 9.92
Book Value/Share 33.24
Interest Coverage -2.30
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar